GSK3B and lung carcinoma: In the present study, the novel anticancer activity of TDB, a bibenzyl from D. ellipsophyllum, towards CSCs of human lung cancer cells is revealed as evidenced by the suppression of tumor initiation and self-renewal properties associated with downregulation of Akt/GSK3β/β-catenin signal and related proteins (Figure 8).